Inventor
Clark E. Tedford
Inventor
Poulsbo, WA, US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07DHeterocyclic compounds11%
C07KPeptides11%
C12YEnzymes9%
C12NMicroorganisms or enzymes8%
A01NPreservation of bodies of humans or animals or plants or parts thereof6%
A61FFilters implantable into blood vessels5%
A61NElectrotherapy5%
A01KAnimal husbandry2%
PatentTitleYear
10,881,550Multi-wavelength phototherapy systems and methods for the treatment of damaged or diseased tissue202110,683,367Compositions for inhibiting MASP-2 dependent complement activation202010,596,037Devices and methods for non-invasive multi-wavelength photobiomodulation for ocular treatments202010,219,944Devices and methods for non-invasive multi-wavelength photobiomodulation for ocular treatments201910,047,165Compositions for inhibiting MASP-2 dependent complement activation20189,855,246'Stable preservative-free mydriatic and anti-inflammatory solutions for injection'20189,486,406'Stable preservative-free mydriatic and anti-inflammatory solutions for injection'20169,475,885'Compositions for inhibiting MASP-2 dependent complement activation'20169,066,856'Stable preservative-free mydriatic and anti-inflammatory solutions for injection'20159,011,860'Compositions for inhibiting MASP-2 dependent complement activation'20158,840,893'Methods for treating conditions associated with MASP-2 dependent complement activation'20148,652,477'Methods for treating disseminated intravascular coagulation by inhibiting MASP-2 dependent complement activation'20147,919,094'Methods for treating conditions associated with MASP-2 dependent complement activation'20116,448,282'1H-4(5)-substituted imidazole derivatives'20026,166,060'1H-4(5)-substituted imidazole derivatives'20006,072,057'1H-4(5)-cyclo-substituted imidazole derivatives as histamine H.sub.3 receptor agents'20006,008,240'2-(1H-4(5)-imidazoyl) cyclopropyl derivatives'19995,990,317'2-(1H-4(5)-imidazoyl) cyclopropyl compounds'19995,652,258'2-(4-imidazoyl) cyclopropyl derivatives'19975,486,526'Histamine H.sub.3 -receptor antagonists and therapeutic uses thereof'1996Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1996–2002Patents assigned to GLIATECH INC (7)· patent assignee history
1996–2002Based in South Russell, OH, US· patent location history
1999–2000Based in South Lebanon, OH, US· patent location history
2011–2020Patents assigned to OMEROS CORP (10)· patent assignee history
2011–2021Based in Poulsbo, WA, US· patent location history
2014–2015Patents assigned to DUDLER THOMAS (3)· patent assignee history
2014–2015Patents assigned to TEDFORD CLARK E (3)· patent assignee history
2019–2021Patents assigned to LUMITHERA INC (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| OMEROS CORP | 10 | 2011–2020 |
| GLIATECH INC | 7 | 1996–2002 |
| DUDLER THOMAS | 3 | 2014–2015 |
| LUMITHERA INC | 3 | 2019–2021 |
| TEDFORD CLARK Eself | 3 | 2014–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Poulsbo, Washington, US | 13 | 2011–2021 |
| South Russell, OH, US | 5 | 1996–2002 |
| South Lebanon, OH, US | 2 | 1999–2000 |